{"id":142335,"date":"2023-02-21T05:29:13","date_gmt":"2023-02-21T10:29:13","guid":{"rendered":"https:\/\/44.250.171.167\/?p=142335"},"modified":"2023-02-21T05:29:48","modified_gmt":"2023-02-21T10:29:48","slug":"earningsabbott-india-ltd-nseabbottindia-q3fy23-results-out-total-income-rise-110-yoy","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/earningsabbott-india-ltd-nseabbottindia-q3fy23-results-out-total-income-rise-110-yoy\/","title":{"rendered":"Earnings|Abbott India Ltd (NSE:ABBOTTINDIA) : Q3FY23 Results Out; Total Income rise 10% YoY"},"content":{"rendered":"\n

Abbott India Ltd (NSE:ABBOTTINDIA)<\/a> is a subsidiary of the global healthcare company, Abbott Laboratories. It was established in 1944 and is headquartered in Mumbai, India. The company’s products and services include pharmaceuticals, medical devices, and diagnostics. Abbott India provides a range of medicines across multiple therapeutic areas such as gastroenterology, women\u2019s health, neurology, and more. The company also offers medical devices for areas such as diabetes care, nutritional supplements, and diagnostic products for various diseases. Abbott India’s mission is to improve the health and well-being of people in India and to become the most valued healthcare company in the country.<\/p>\n\n\n\n

Abbott India Ltd, reported strong financial results for the period ended December 31, 2021. Despite a slower revenue growth rate of 8.3% compared to Q2FY23, the company’s net income exceeded expectations. Abbott India’s PAT surged 23.9%, and its EBITDA margin expanded by 188 basis points year-on-year to 23.9%.<\/p>\n\n\n\n

The company’s operating performance was strong, with major operating costs declining year-on-year, driving up EBITDA margins. Gross margins, however, fell by 320 basis points. The company’s employee and other expenses also decreased year-on-year as a percentage of revenue.<\/p>\n\n\n\n

Abbott India’s total income for the period ended December 31, 2021, was Rs. 1243.10 crores, compared to Rs. 1110.38 crores during the period ended December 31, 2020. The company’s net profit for the period ended December 31, 2021, was Rs. 199.20 crores, compared to Rs. 177.14 crores during the same period in the previous year. The company’s EPS for the period ended December 31, 2021, was Rs. 93.74, compared to Rs. 83.36 for the period ended December 31, 2020.<\/p>\n\n\n\n

The company’s revenues and earnings are projected to grow at a CAGR of 11.0% and 19.0%, respectively, over the period FY2022-FY2025E, due to healthy growth prospects and a strong brand equity. Abbott India is expected to benefit from growth opportunities in the Indian healthcare sector, including rising demand for quality healthcare, increased access to healthcare services, and increased spending on healthcare.<\/p>\n\n\n\n

Overall, Abbott India’s strong financial results reflect the company’s successful execution of its growth strategy and its focus on delivering innovative healthcare products and services that meet the needs of Indian consumers.<\/p>\n","protected":false},"excerpt":{"rendered":"

Abbott India Ltd (NSE:ABBOTTINDIA) is a subsidiary of the global healthcare company, Abbott Laboratories. It was established in 1944 and is headquartered in Mumbai, India. The company’s products and services include pharmaceuticals, medical devices, and diagnostics. Abbott India provides a range of medicines across multiple therapeutic areas such as gastroenterology, women\u2019s health, neurology, and more. […]<\/p>\n","protected":false},"author":1932,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392,5747],"tags":[1115],"class_list":["post-142335","post","type-post","status-publish","format-standard","hentry","category-earnings","category-healthcare-stocks","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":146768,"url":"https:\/\/alphastreet.com\/india\/earnings-abbott-india-ltd-nse-abbottindia-q4fy23-results-out-total-income-rises-9-yoy\/","url_meta":{"origin":142335,"position":0},"title":"Earnings | Abbott India Ltd (NSE: ABBOTTINDIA): Q4FY23 Results Out; Total Income rises 9% YoY.","author":"Divyansh_Kasana","date":"May 19, 2023","format":false,"excerpt":"Abbott India Ltd is a prominent multinational pharmaceutical company operating in India. Established in 1944, it has emerged as a key player in the Indian pharmaceutical industry. The company distributes its products through independent distributors, primarily within the country. With a strong presence in the market, Abbott India offers a\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-4-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-4-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-4-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-4-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-4-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-4-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":140957,"url":"https:\/\/alphastreet.com\/india\/abbott-india-ltd-ltd-nse-abbottindia-q3-fy23-results-out-total-income-rises-10-yoy\/","url_meta":{"origin":142335,"position":1},"title":"ABBOTT INDIA LTD Ltd. (NSE: ABBOTTINDIA): Q3 FY23 Results Out; Total Income Rises 10% YoY","author":"Divyansh_Kasana","date":"February 10, 2023","format":false,"excerpt":"Abbott India Limited (NSE:ABBOTTINDIA) is a subsidiary of Abbott Laboratories, a multinational healthcare company. It was established in India in 1944 and is headquartered in Mumbai. The company operates in the pharmaceutical and medical devices industries, offering a wide range of products, including prescription medicines, diagnostic equipment, and nutritional products.\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/57ca1fbd-1e9f-4485-9d2a-390769e80ed6.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/57ca1fbd-1e9f-4485-9d2a-390769e80ed6.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/57ca1fbd-1e9f-4485-9d2a-390769e80ed6.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/57ca1fbd-1e9f-4485-9d2a-390769e80ed6.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/57ca1fbd-1e9f-4485-9d2a-390769e80ed6.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/57ca1fbd-1e9f-4485-9d2a-390769e80ed6.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165734,"url":"https:\/\/alphastreet.com\/india\/abbott-india-ltd-q2fy25-43-fall-in-profits\/","url_meta":{"origin":142335,"position":2},"title":"Abbott India Ltd Q2FY25; 43% fall in Profits","author":"Divyansh_Kasana","date":"November 20, 2024","format":false,"excerpt":"Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India. It was established in 1944. Financial Results: Abbott India Ltd reported Revenues for Q2FY25 of \u20b91,628.00 Crores up from \u20b9497.00 Crore year on year, a rise of\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/JR.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/JR.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/JR.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/JR.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/JR.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/JR.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168601,"url":"https:\/\/alphastreet.com\/india\/abbott-india-ltd-q4fy25-87-rise-in-profits\/","url_meta":{"origin":142335,"position":3},"title":"Abbott India Ltd Q4FY25; 87% rise in Profits","author":"Divyansh_Kasana","date":"June 2, 2025","format":false,"excerpt":"Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India. It was established in 1944. Financial Results: Abbott India Ltd reported Revenues for Q4FY25 of \u20b96,375.00 Crores up from \u20b94,707.00 Crore year on year, a rise of\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166980,"url":"https:\/\/alphastreet.com\/india\/abbott-india-ltd-q3fy25-88-fall-in-profits\/","url_meta":{"origin":142335,"position":4},"title":"Abbott India Ltd Q3FY25; 88% fall in Profits","author":"Divyansh_Kasana","date":"February 19, 2025","format":false,"excerpt":"Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India. It was established in 1944. Financial Results: Abbott India Ltd reported Revenues for Q3FY25 of \u20b922,848.00 Crores down from \u20b925,050.00 Crore year on year, a fall of\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/L-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/L-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/L-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/L-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/L-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/L-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":141647,"url":"https:\/\/alphastreet.com\/india\/biocon-ltd-nse-biocon-ltd-q3-fy23-results-out-total-income-rise-35-yoy\/","url_meta":{"origin":142335,"position":5},"title":"Biocon ltd.(NSE: BIOCON) Ltd. : Q3 FY23 Results Out; Total Income rise 35% YoY","author":"Divyansh_Kasana","date":"February 14, 2023","format":false,"excerpt":"Biocon Limited (NSE:BIOCON) is an Indian multinational biopharmaceutical company based in Bangalore, India. The company was founded in 1978 by Kiran Mazumdar-Shaw and is now one of the largest biopharmaceutical companies in India. Biocon is primarily engaged in the production of biosimilars, generic biologics, and research-based pharmaceuticals. It also has\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/5ae0e933-d8c2-4fc6-912a-65a97b6504cf.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/5ae0e933-d8c2-4fc6-912a-65a97b6504cf.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/5ae0e933-d8c2-4fc6-912a-65a97b6504cf.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/5ae0e933-d8c2-4fc6-912a-65a97b6504cf.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/5ae0e933-d8c2-4fc6-912a-65a97b6504cf.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/5ae0e933-d8c2-4fc6-912a-65a97b6504cf.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/142335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=142335"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/142335\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=142335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=142335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=142335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}